PRF Technologies (PRFX) Cash & Current Investments (2019 - 2026)
PRF Technologies' (PRFX) quarterly Cash & Current Investments came in at $11.5 million in Q2 2026, up 230.14% on a YoY basis from $3.5 million in Q2 2025, and up 178.56% quarter-over-quarter from $4.1 million in Q4 2025.
PRF Technologies (PRFX) Cash & Current Investments (2019 - 2026) Analysis & Trends
PRF Technologies (PRFX) has reported Cash & Current Investments for 8 consecutive years, with $11.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Current Investments rose 230.14% year-over-year to $11.5 million; the trailing twelve-month figure through Jun 2026 stood at $11.5 million (up 230.14% YoY), and the FY2025 full-year result was $4.1 million, down 2.82% from the prior year.
- Cash & Current Investments improved to $11.5 million in Q2 2026 per PRFX's latest filing, from $4.1 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $16.6 million in Q1 2022 and bottomed at $2.8 million in Q2 2024.
- Historically, Cash & Current Investments has averaged $8.2 million across 5 years, with a median of $8.1 million in 2023.
- The sharpest annual moves came in 2023 and 2026: Cash & Current Investments plunged 55.57% in 2023, then surged 230.14% in 2026.
- Over 5 years, Cash & Current Investments stood at $10.2 million in 2022, then decreased by 21.17% to $8.0 million in 2023, then plunged by 46.91% to $4.3 million in 2024, then retreated by 2.82% to $4.1 million in 2025, then soared by 178.56% to $11.5 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $11.5 million, $4.1 million, and $3.5 million for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 46.72 Bn | 43.07 Bn | 2.15 Bn | 3.66 Bn |
| 2 | Viatris | 19.64 Bn | 18.75 Bn | 1.46 Bn | 886.50 Mn |
| 3 | Dr Reddys Laboratories | 10.36 Bn | 10.22 Bn | 396.53 Mn | 171.67 Mn |
| 4 | Amneal Pharmaceuticals | 6.44 Bn | 6.39 Bn | 334.51 Mn | 127.64 Mn |
| 5 | Bausch Health Companies | 2.11 Bn | 1.24 Bn | 2.10 Bn | 1.84 Bn |
| 6 | Ani Pharmaceuticals | 1.88 Bn | 1.52 Bn | 165.89 Mn | 360.25 Mn |
| 7 | Alvotech | 1.83 Bn | 1.69 Bn | 2.56 Mn | 142.75 Mn |
| 8 | Amphastar Pharmaceuticals | 1.04 Bn | 751.07 Mn | 93.47 Mn | 290.12 Mn |
| 9 | Fennec Pharmaceuticals | 382.22 Mn | 340.97 Mn | 17.15 Mn | 41.25 Mn |
| 10 | PRF Technologies | 622,054.07 | -10.31 Mn | - | 11.54 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.54 Mn |
| Dec 31, 2025 | 4.14 Mn |
| Jun 30, 2025 | 3.49 Mn |
| Dec 31, 2024 | 4.26 Mn |
| Jun 30, 2024 | 2.79 Mn |
| Mar 31, 2024 | 4.32 Mn |
| Dec 31, 2023 | 8.03 Mn |
| Sep 30, 2023 | 8.58 Mn |
| Jun 30, 2023 | 6.16 Mn |
| Mar 31, 2023 | 8.15 Mn |
| Dec 31, 2022 | 10.18 Mn |
| Sep 30, 2022 | 12.98 Mn |
| Jun 30, 2022 | 13.87 Mn |
| Mar 31, 2022 | 16.57 Mn |
| Dec 31, 2021 | 16.54 Mn |
| Sep 30, 2021 | 18.34 Mn |
| Jun 30, 2021 | 17.80 Mn |
| Mar 31, 2021 | 19.44 Mn |
| Dec 31, 2020 | 15.68 Mn |
| Sep 30, 2020 | 17.72 Mn |
PRF Technologies Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PRFX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "PRFX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=PRFX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();